Document:

Exhibit 10.5

     

    

    AGREEMENT

     

    

    This Agreement (this “Agreement”), dated as of June 3, 2020, is entered into by and among Blake Enterprises I, Inc., a Delaware corporation, Blake Enterprises II, Inc., a Delaware corporation, and Blake
      Enterprises III, Inc., a Delaware corporation (collectively, the “Baker Entities”), Blake Baker, Compstar Holding Company LLC, a Delaware limited liability company (the “Company”), Trean Holdings LLC, a Delaware limited liability
      company (“Trean”), and Trean Compstar Holdings LLC, a Delaware limited liability company (“Trean Compstar”).  Capitalized terms used and not defined in this Agreement shall have the respective meanings ascribed to such terms in the
      Company’s Limited Liability Company Agreement, dated as of April 2, 2018 (as amended) (the “LLC Agreement”).

     

    

    1.           (a)          In connection with any Initial Public Offering for the IPO Entity (as such terms are defined below) that occurs before December 31, 2020 and promptly after the closing (the “Closing”) of
      reorganization transactions pursuant to which the equity interests, or all or substantially all of the assets and liabilities, of Trean and of BIC Holdings LLC (“BIC”) will be directly or indirectly contributed or transferred to the IPO Entity
      in exchange for shares of common stock (“Common Stock”) in the IPO Entity (the “Trean and BIC Reorganization”), the transactions set forth in subsections (i) through (iii) of this Section 1(a) shall be effected by the parties to this
      Agreement (and the parties to this Agreement will not conduct an Initial Public Offering of the IPO Entity prior to December 31, 2020 without effecting the Trean and BIC Reorganization and the transactions set forth in the following subsections (i)
      through (iii) of this Section 1(a)):

     

    

    (i)          the Baker Entities will (and will cause their Permitted Transferees to) substantially concurrent with the Closing, exchange all of their Class B Units (and all rights under the LLC Agreement relating
      thereto) for a number of shares of Common Stock (to be allocated amongst the Baker Entities in the same proportions in which the Baker Entities hold Class B Units as of immediately prior to the Exchange) of the IPO Entity equal to an aggregate of
      14.45% of the total number of shares of Common Stock of the IPO Entity outstanding immediately before giving effect to the shares of Common Stock to be issued in the Initial Public Offering for the IPO Entity (and calculated without giving effect to
      (i.e., without counting) (A) any shares of Common Stock issuable upon the exercise of any greenshoe option in connection with the Initial Public Offering, and (B) up to an additional number of shares of Common Stock issuable upon the exercise of
      options or warrants (excluding the greenshoe option described in the foregoing clause (A)) that are then outstanding and that, if exercised, would be equal to two percent (2%) of the fully-diluted shares of Common Stock of the IPO Entity at such
      time) (such exchange transaction, the “Exchange”);

     

    

    (ii)         the Baker Entities will (and will cause their Permitted Transferees to) sell in the Initial Public Offering, on the same terms as the other shares of Common Stock of the IPO Entity that are being sold in
      the Initial Public Offering (including by entering into customary agreements (including underwriting and lockup agreements) requested by the IPO Entity or the underwriters in connection therewith), a number of shares of Common Stock of the IPO Entity
      received by them in the Exchange that would result in the Baker Entities and their Permitted Transferees owning an aggregate of 9.99% of the total number of shares of Common Stock of the IPO Entity outstanding immediately after giving effect to the
      completion of the Initial Public Offering (calculated before giving effect to the exercise of any greenshoe option in connection with the Initial Public Offering, and calculated without giving effect to any Common Stock issuable upon the exercise of
      any options or warrants); provided that all Registration Expenses (as defined below, and excluding, for the avoidance of doubt, any selling commissions, underwriter discounts or similar fees, and legal fees and expenses of legal counsel and other
      advisors of the Baker Entities, if any) shall be borne by the IPO Entity. “Registration Expenses” means all expenses of the IPO Entity in connection with the Initial Public Offering, including without limitation all registration and filing
      fees, fees and expenses of compliance with securities or blue sky laws, printing expenses, travel expenses, filing expenses, messenger and delivery expenses, fees and disbursements of custodians, reimbursement of fees and expenses of the
      underwriter(s) for the Initial Public Offering (to the extent the Company is responsible for such reimbursement, and excluding, for the avoidance of doubt, selling commissions, underwriter discounts and similar fees applicable to the Common Stock to
      be sold by the Baker Entities in the Initial Public Offering) and fees and disbursements of counsel for the IPO Entity, fees and disbursements of all independent certified public accountants of the IPO Entity, the expense of any annual audit or
      quarterly review of the IPO Entity, and the expenses and fees for listing the Common Stock of the IPO Entity to be registered on any applicable securities exchange; and

    
      
        

    

    
    (iii)        substantially concurrent with such Closing, (A) Blake Baker will, and the Company will cause OpCo to, enter into an amendment to the Employment Agreement between Blake Baker and Opco, dated as of April 2,
      2018, in the form attached as Exhibit A hereto, it being understood and agreed that such amendment will not limit or affect the covenants and agreements contained in Section 5 of the Management Incentive Unit Agreement between the Company and
      Blake Baker, which Management Incentive Unit Agreement will continue in effect after such Closing, and (B) the LLC Agreement will terminate and cease to apply without any further action by the parties thereto immediately following the completion of
      the Exchange and the contribution by the IPO Entity to Trean Compstar of the Class B Units acquired by the IPO Entity in the Exchange; provided, however, that (1) the rights and obligations of the parties to the LLC Agreement under
      Sections 13.1 and 13.2 thereto (Exculpation and Indemnification) with respect to acts or omissions occurring prior to the Closing shall survive the termination of the LLC Agreement; (2) the provisions of Article V (Distributions) and Article VI
      (Allocations) shall continue to govern as they relate to periods prior to the Closing; and (3) such termination of the LLC Agreement shall not relieve any party thereto from liability for breaches thereof that occurred prior to such termination. For
      the sake of clarity, and without limiting the generality of previous sentence, the forfeiture restrictions applicable to the Class B Units held by Baker and his Permitted Transferees (including without limitation the Baker Entities) and the
      corresponding repurchase rights, each as set forth in Section 9.3 of the LLC Agreement, will automatically terminate upon the occurrence of the Exchange and be of no further force or effect, and shall not apply to any shares of Common Stock of the
      IPO Entity acquired by the Baker Entities in the Exchange.

     

    

    (b)          As used in this Agreement, (i) “Initial Public Offering” means an initial public offering of the securities of the IPO Entity in accordance with the provisions of the Securities Act, other than
      pursuant to a registration statement on Form S-4 or Form S-8 or any similar or successor form, and (ii) “IPO Entity” means any of Trean, BIC, any direct or indirect parent, subsidiary or other Affiliate of or successor to Trean or BIC, or any
      other Person that acquires all or substantially all of the equity interests or the assets and liabilities of Trean and BIC, that in any such case is the issuer of Common Stock in an Initial Public Offering (which entity may be formed after the date
      hereof), which shall for applicable purposes hereunder be deemed to be a Successor Entity under the LLC Agreement.

     

    

    (c)          In connection with the Exchange, (i) the Baker Entities represent that the amount of consolidated EBITDA of the Company for the twelve-month period ended December 31, 2019 (“Consolidated Company EBITDA”),

      as disclosed by the Baker Entities to Trean Compstar prior to the date hereof, was derived from the books and records of the Company and its subsidiaries, which books and records are accurate and complete in all material respects, and calculated in
      all material respects in accordance with U.S. generally accepted accounting principles (“GAAP”), and (ii) Trean Compstar represents that the combined EBITDA of Trean and its subsidiaries (other than the Company and its subsidiaries) and BIC
      and its subsidiaries for the twelve-month period ended December 31, 2019 (“Combined Trean/BIC EBITDA”), as disclosed by Trean or its Affiliates to Blake Baker prior to the date hereof, was derived from the books and records of Trean and its
      subsidiaries (other than the Company and its subsidiaries) and BIC and its subsidiaries, which books and records are accurate and complete in all material respects, and calculated in all material respects in accordance with GAAP, except that (A)
      certain items and amounts included in the calculation of Combined Trean/BIC EBITDA were not calculated in accordance with GAAP but were calculated in all material respects in accordance with the historical accounting practices of Trean and its
      subsidiaries (other than the Company and its subsidiaries) and BIC and its subsidiaries, and with respect to those items and amounts not calculated in accordance with GAAP, Trean or its Affiliates has provided to Baker and the Baker Entities the
      adjustments that have been made to the Combined Trean/BIC EBITDA in respect of such non-GAAP items (the “Adjustments”), and (B) for the avoidance of doubt, no portion of the Consolidated Company EBITDA was included in the Combined Trean/BIC
      EBITDA.  Trean Compstar further represents that the Adjustments (which increase the Combined Trean/BIC EBITDA) are reversals of actual expenses taken into account in the pre-Adjustment calculation of the Combined Trean/BIC EBITDA.

    
      2

      
        

    

    (d)          The parties to this Agreement intend that the Trean and BIC Reorganization, the Initial Public Offering (together with the exercise of any greenshoe option in connection with the Initial Public Offering) and
      the transaction set forth in subsection (i) of Section 1(a) above will be treated as part of an integrated transaction qualifying for tax-free treatment under Section 351 of the Code (subject to the application of Section 351(h)(1) and Section 357 of
      the Code), and shall not take any position on a tax return or otherwise that is inconsistent with such treatment, except as required by law. The parties agree that they will not enter into any transactions, including but not limited to the sale of
      shares or the grant of options and excluding the sale of Common Stock by stockholders in the Initial Public Offering, that would result in the control requirement of Section 351(a) of the Code not being satisfied immediately after the completion of
      such integrated transaction.

     

    

    (e)          The parties to this Agreement acknowledge that the percentage of shares of Common Stock of the IPO Entity to be issued to the Baker Entities in the Exchange (i.e., 14.45%) was  calculated based, in part,
      upon the respective capitalizations (including without limitation levels of indebtedness) of the Company, Trean and BIC as of December 31, 2019.  If a material change to the capitalization of the Company, Trean or BIC occurs after December 31, 2019
      and prior to the consummation of the Initial Public Offering (other than the Trean and BIC Reorganization, the Exchange, and the transactions contemplated by and relating to the Trean and BIC Reorganization and the Exchange), the parties hereto agree
      to equitably adjust the percentage of shares of Common Stock of the IPO Entity to be issued to the Baker Entities in the Exchange in the same manner as would have been effected had such change occurred as of December 31, 2019 in order to equitably
      reflect the purposes and intentions of the parties in entering into this Agreement (it being understood that if any such change results in the Baker Entities receiving a larger percentage of the shares of Common Stock of the IPO Entity in the
      Exchange than is provided in Section 1(a)(i) above, the Baker Entities will still be required to sell a sufficient number of shares of Common Stock in the IPO as contemplated by Section 1(a)(ii) above such that the aggregate ownership of shares of
      Common Stock by the Baker Entities will be 9.99% of the total number of shares of Common Stock of the IPO Entity outstanding immediately after giving effect to the completion of the Initial Public Offering (calculated before giving effect to the
      exercise of any greenshoe option in connection with the Initial Public Offering, and calculated without giving effect to any Common Stock issuable upon the exercise of any options or warrants).

     

    

    2.           Representations and Warranties of Baker and the Baker Entities. Baker and the Baker Entities hereby jointly and severally represent and warrant to Trean, Trean Compstar and the IPO Entity as follows:

     

    

    (a)          Ownership; No Encumbrances. Immediately prior to the Exchange, the Baker Entities will be the only record and beneficial owner of the Class B Units, with good and marketable title thereto, free and
      clear of all liens, pledges, charges and other encumbrances and restrictions of any nature (other than the pledge of such Class B Units in favor of Oak Street Funding LLC, which the parties hereto agree to use commercially reasonable efforts to
      remove (or to replace with a similar pledge by Trean Compstar of such Class B Units following the Exchange), and are not subject to any adverse claim thereon (other than with respect to any restrictions on transfer imposed by the LLC Agreement, which
      the parties hereto hereby waive solely in connection with effecting the Exchange).

    
      3

      
        

    

    (b)          Authority.  Each of the Baker Entities has the requisite power and authority to execute and deliver this Agreement, to perform its respective obligations hereunder and to consummate the transactions
      contemplated hereby. This Agreement has been duly and validly executed and delivered by Baker and each of the Baker Entities. The execution, delivery and performance of this Agreement has been duly authorized by each of the Baker Entities. The
      execution and delivery of this Agreement and performance by Baker and each of the Baker Entities of his or its respective obligations hereunder, the consummation of the transactions contemplated hereby and the compliance by Baker and each of the
      Baker Entities with any of the provisions hereof will not (i) violate or conflict with the organizational documents of each of the Baker Entities, (ii) violate or conflict with any action, suit or order affecting any of the Baker Entities or the
      Class B Units, or (iii) require any consent or other action by any other Person under, or constitute a default under, any provision of any contract, agreement or other instrument to which Baker or any of the Baker Entities is a party or to which
      Baker or any of the Baker Entities assets are bound (other than with respect to any restrictions on transfer imposed by the LLC Agreement, which the parties hereto hereby waive solely in connection with effecting the Exchange). This Agreement
      constitutes the valid and binding obligation of Baker and each of the Baker Entities, enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law
      governing specific performance, injunctive relief or other equitable remedies.

     

    

    (c)          Accredited Investor.  Each of the Baker Entities is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D, promulgated under the Securities Act of 1933, as amended, and the
      rules and regulations thereunder, or any successor federal law then in force.

     

    

    (d)          Access to Information. Each of Baker and the Baker Entities has had an opportunity to ask Trean questions and receive answers regarding the IPO Entity and Trean’s and BIC’s operations and financial
      performance and has had access to such other information concerning the IPO Entity and Trean’s and BIC’s operations and financial performance as Baker and the Baker Entities has requested.

     

    

    (e)          Independent Analysis.  Each of Baker and the Baker Entities has conducted its own independent investigation into the IPO Entity, Trean, BIC, their respective businesses and their respective prospects
      and has relied solely on the results of its own due diligence inquiries, and the representations and warranties of Trean and Trean Compstar contained herein.

     

    

    (f)          No General Solicitation. None of Baker or the Baker Entities is entering into this Agreement as a result of any advertisement, article, notice or other communication regarding the transactions
      contemplated hereby published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

     

    

    3.           Representations and Warranties of Trean and Trean Compstar.  Trean and Trean Compstar hereby jointly and severally represent and warrant to each of the Baker Entities as follows:

     

    

    (a)          Issuance; No Encumbrances. At the time of the Exchange, the IPO Entity will have the authority to issue the Common Stock to be issued in the Exchange.  Immediately following the consummation of the
      Exchange, the Baker Entities will acquire good title to the Common Stock to be issued to the Baker Entities in the Exchange, free and clear of all liens, pledges, charges and other encumbrances and restrictions of any nature (subject to any such
      encumbrances that may be imposed as a result of any agreements or obligations of Baker or the Baker Entities, and subject to any restrictions under applicable securities laws).

    
      4

      
        

    

    (b)          Authority.  Each of Trean and Trean Compstar has the requisite power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions
      contemplated hereby. This Agreement has been duly and validly executed and delivered by Trean and Trean Compstar. The execution, delivery and performance of this Agreement has been duly authorized by Trean and Trean Compstar. The execution and
      delivery of this Agreement and performance by Trean and Trean Compstar of their respective obligations hereunder, the consummation of the transactions contemplated hereby and the compliance by Trean and Trean Compstar with any of the provisions
      hereof will not (i) violate, or conflict with, the organizational documents of Trean or Trean Compstar, (ii) violate or conflict with any action, suit or order affecting Trean or Trean Compstar, or (iii) require any consent or other action by any
      other Person under, or constitute a default under, any provision of any contract, agreement or other instrument to which Trean or Trean Compstar is a party or to which any of Trean’s or Trean Compstar’s assets are bound. This Agreement constitutes
      the valid and binding obligation of Trean and of Trean Compstar, enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific
      performance, injunctive relief or other equitable remedies.

     

    

    (c)          Access to Information. Trean and Trean Compstar have had an opportunity to ask Baker and the Baker Entities questions and receive answers regarding the Company and the Company’s operations and
      financial performance and have had access to such other information concerning the Company and the Company’s operations and financial performance as Trean and Trean Compstar have requested.

     

    

    4.           Sections 17.7-17.10, 17.12-17.13 and 17.21 of the LLC Agreement shall apply to this Agreement as if fully set forth herein (notwithstanding Section 1(a)(iii)(B) above),
      mutatis mutandis.  This Agreement shall not be assignable by any party without the prior written consent of the other parties hereto, except that the Company, Trean and Trean Compstar may assign any or all of
      their rights hereunder to the IPO Entity. This Agreement and the other documents referred to herein embody the entire agreement and understanding among the parties hereto with respect to the subject matter hereof and supersede and preempt all prior
      understandings or agreements by or among such parties which may have related to the subject matter hereof, and in the event of any conflict between the terms of this Agreement and the LLC Agreement, the terms of this Agreement shall control. This
      Agreement may be amended only by the mutual written agreement of the parties hereto.  This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which taken together shall be considered one and the
      same agreement.  In the event that any signature to this Agreement is delivered by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is
      executed) with the same force and effect as if such “.pdf” signature page were an original thereof.

     

    

    [Signature page follows]

    
      5

      
        

    

    IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first written above.

     

    

    	 	
            COMPSTAR HOLDING COMPANY LLC

          
	 	 	 	 
	 	
            By:

          	/s/ Andrew M. O'Brien

          
	 	 	
            Name:

          	
            Andrew M. O’Brien

          
	 	 	
            Title:

          	
            Authorized Signatory

          

    

    

    	 	
            TREAN COMPSTAR HOLDINGS LLC

          
	 	 	 	 
	 	
            By:

          	/s/ Andrew M. O'Brien

          
	 	 	
            Name:

          	
            Andrew M. O’Brien

          
	 	 	
            Title:

          	
            Authorized Signatory

          

    

    

    	 	
            TREAN HOLDINGS LLC

          
	 	 	 	 
	 	
            By:

          	/s/ Andrew M. O'Brien

          
	 	 	
            Name:

          	
            Andrew M. O’Brien

          
	 	 	
            Title:

          	
            Authorized Signatory

          
	 	 	 	 
	 	By:

          	/s/ Blake Baker  

          
	 	 Blake Baker

          

    

    

    	 	
            BLAKE ENTERPRISE I, INC.

          
	 	
            BLAKE ENTERPRISES II, INC.

          
	 	
            BLAKE ENTERPRISES III, INC.

          
	 	 	 	 
	 	
            By:

          	/s/ Blake Baker

          
	 	 	
            Name:

          	
            Blake Baker

          
	 	 	
            Title:

          	
            President

          

    
      
        

    

    Exhibit A

    

    

    FIRST AMENDMENT TO EMPLOYMENT AGREEMENTExhibit 10.6

    

     

    

    
      DIRECTOR NOMINATION AGREEMENT

      

      

      DIRECTOR NOMINATION AGREEMENT, dated as of          , 2020 (this “Agreement”), by and among Trean Insurance Group, Inc., a Delaware corporation (the “Company”), AHP-BHC LLC, AHP-TH LLC, ACP-BHC LLC and
        ACP TH LLC (collectively, together with their respective Permitted Transferees, the “Altaris Funds”).

      

      

      WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (“IPO”) of shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”);
        and

      

      

      WHEREAS, in connection with the IPO, the Company and the Altaris Funds desire to enter into this Agreement setting forth certain rights and obligations with respect to the nomination of directors to the Board of
        Directors of the Company (the “Board”) and other matters relating to the Board from and after the IPO.

      

      

      NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

      

      

      Section 1.   Definitions. As used in this Agreement, the following terms shall have the meanings ascribed to them below:

      

      

      “Affiliate” means, with respect to a specified Person, any Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, the Person
        specified. For purposes of this definition, “control” (including the terms “controlling,” “controlled by” and “under common control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and
        policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

      

      

      “By-Laws” means the Amended and Restated By-Laws of the Company, as may be amended from time to time.

      

      

      “First Threshold Date” means the first date on which the Altaris Funds cease to beneficially own 35% or more of the total number of shares of Common Stock outstanding.

      

      

      “Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the Company, as may be amended from time to time.

      

      

      “Permitted Transferee” shall mean, with respect to the Altaris Funds, (i) any Affiliates of the Altaris Funds, which for purposes of this definition only includes any investment fund or holding company that is
        directly or indirectly managed or advised by the same manager or investment adviser as the Altaris Funds or by an Affiliate of such manager or investment adviser, and (ii) any member or general or limited partner of the Altaris Funds.

      

      

      
        
          

      

      
      “Person” means any individual, corporation, partnership, limited liability company, joint venture, association, trust or other entity or organization, including a government or political subdivision or an agency
        or instrumentality thereof.

      

      

      “Second Threshold Date” means the first date on which the Altaris Funds cease to beneficially own 20% or more of the total number of shares of Common Stock outstanding.

      

      

      “Third Threshold Date” means the first date on which the Altaris Funds cease to beneficially own 10% or more of the total number of shares of Common Stock outstanding.

      

      

      Section 2.   Board Number; Board Nomination.

      

      

      (a)       Until the First Threshold Date, the Altaris Funds shall have the right (but not the obligation) pursuant to this Agreement to submit for
          nomination to the Board three (3) individuals and the Company shall obtain any necessary approvals from the Board, the Compensation, Nominating and Corporate Governance Committee of the Board or other duly authorized committee of the Board and
          shall include in the slate of nominees recommended to stockholders of the Company (the “Stockholders”) for election as a director at any annual or special meeting of the Stockholders (or, if permitted,
          by any action by written consent of the Stockholders) at which directors of the Company are to be elected, the up to three individuals identified in advance by the Altaris Funds.

      

      

      (b)       After the First Threshold Date and until the Second Threshold Date, the Altaris Funds shall have the right (but not the obligation)
          pursuant to this Agreement to submit for nomination to the Board two (2) individuals and the Company shall obtain any necessary approvals from the Board, the Compensation, Nominating and Corporate Governance Committee of the Board or other duly
          authorized committee of the Board and shall include in the slate of nominees recommended to the Stockholders for election as a director at any annual or special meeting of the Stockholders (or, if permitted, by any action by written consent of
          the Stockholders) at which directors of the Company are to be elected, the up to two individuals identified in advance by the Altaris Funds.

      

      

      (c)       After the Second Threshold Date and until the Third Threshold Date, the Altaris Funds shall have the right (but not the obligation)
          pursuant to this Agreement to submit for nomination to the Board one (1) individual and the Company shall obtain any necessary approvals from the Board, the Compensation, Nominating and Corporate Governance Committee of the Board or other duly
          authorized committee of the Board and shall include in the slate of nominees recommended to the Stockholders for election as a director at any annual or special meeting of the Stockholders (or, if permitted, by any action by written consent of
          the Stockholders) at which directors of the Company are to be elected, the one individual identified in advance by the Altaris Funds (any such individuals identified pursuant to Section 2(a), Section 2(b) or Section 2(c) hereof, the “Altaris

          Nominees”).

      

      

      (d)       In the event that the Altaris Funds have nominated less than the total number of individuals that the Altaris Funds shall be entitled to
          nominate pursuant to this Section 2(a), Section 2(b) or Section 2(c), then the Altaris Funds shall have the right, at any time, to nominate such additional individual(s) to which the Altaris Funds are entitled, in which case, the Company shall
          cause the Board to take all necessary corporate action to (1) increase the size of the Board as required to enable the Altaris Funds to so nominate such additional individuals and (2) nominate such additional individuals identified by the Altaris
          Funds to fill such newly created vacancies.

       

        

      
        2

        
          

      

      (e)       Vacancies arising through the death, resignation or removal of any Altaris Nominee who was nominated to the Board pursuant to this Section
          2, may be filled by the Board only with a Altaris Nominee, and the director so chosen shall hold office until the next election and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or
          removal.

      

      

      (f)       Notwithstanding the provisions of this Section 2, the Altaris Funds shall not be entitled to designate a Person as a nominee to the Board
          upon a written determination by the Compensation, Nominating and Corporate Governance Committee of the Board or equivalent duly authorized committee of the Board with nominating responsibility (which determination shall set forth in writing
          reasonable grounds for such determination) that such Person would not be qualified under any applicable law, rule or regulation to serve as a director of the Company. In such an event, the Altaris Funds shall be entitled to select a Person as a
          replacement nominee and the Company shall cause such Person to be nominated as the Altaris Nominee at the same meeting (or, if permitted, pursuant to the same action by written consent of the Stockholders) as such initial Person was to be
          nominated. Other than with respect to the issue set forth in the first sentence of this Section 2(f), neither the Company nor any other party to this Agreement shall have the right to object to any Altaris Nominee. Notwithstanding anything in
          this Agreement to the contrary, no Altaris Nominee shall be required to qualify as an independent director under applicable rules or regulations of the U.S. Securities and Exchange Commission or a stock exchange on which shares of Common Stock
          are listed.

      

      

      (g)       Until the Third Threshold Date, the Company shall notify the Altaris Funds in writing of the date on which proxy materials are expected to
          be mailed by the Company in connection with an election of directors at an annual or special meeting of the Stockholders (and the Company shall deliver such notice at least 60 days (or such shorter period to which the Altaris Funds consent, which
          consent need not be in writing) prior to such expected mailing date or such earlier date as may be specified by the Company reasonably in advance of such earlier delivery date on the basis that such earlier delivery is necessary so as to ensure
          that such nominee may be included in such proxy materials at the time such proxy materials are mailed). The Company shall provide the Altaris Funds with a reasonable opportunity to review and provide comments on any portion of the proxy materials
          relating to the Altaris Nominees or the rights and obligations provided under this Agreement and to discuss any such comments with the Company. The Company shall notify the Altaris Funds of any opposition to a Altaris Nominee in accordance with
          Section 2(f) sufficiently in advance of the date on which such proxy materials are to be mailed by the Company in connection with such election of directors so as to enable the Altaris Funds to propose a replacement Altaris Nominee, if necessary,
          in accordance with the terms of this Agreement, and the Altaris Funds shall have 10 business days to identify such replacement Altaris Nominee.

      

      

      
        3

        
          

      

      (h)       The Company shall cause the Board to maintain a Compensation, Nominating and Corporate Governance Committee (or equivalent duly authorized
          committee of the Board) and subject to applicable laws and stock exchange regulations (including any phase in periods or other limitations thereunder), the Altaris Funds shall have the right (but not the obligation) to have a Altaris Nominee that
          is then a director of the Company serve as a member of the Compensation, Nominating and Corporate Governance Committee (or equivalent duly authorized committee of the Board).

      

      

      (i)        In the event that the Altaris Funds cease to have the requisite nomination rights pursuant to Section 2, the Altaris Funds shall use their
          best efforts to cause the applicable Altaris Nominee to resign as promptly as practicable thereafter.

      

      

      (j)        Except as required by applicable law or the listing standards of the stock exchange on which shares of Common Stock are listed and subject
          to Section 2(d) the Company shall not, without the prior written consent of the Altaris Funds, take any action to increase the number of directors on the Board.

      

      

      (k)       So long as this Agreement shall remain in effect, subject to applicable legal requirements, the By-Laws and the Certificate of
          Incorporation shall accommodate and be subject to and not in any respect conflict with the rights and obligations set forth herein.

      

      

      Section 3.   Miscellaneous.

       

      

      (a)       Effective Date. This Agreement shall become effective upon the closing of the IPO.

      

      

      (b)       Governing Law. This Agreement and the rights and obligations of the parties hereto and the Persons subject hereto shall be governed
          by, and construed and interpreted in accordance with, the laws of the State of Delaware, without giving effect to the choice of law principles thereof.

      

      

      (c)       Certain Adjustments. The provisions of this Agreement shall apply to the full extent set forth herein with respect to any and all
          shares of capital stock of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for, or in substitution for the shares of Common
          Stock, by combination, recapitalization, reclassification, merger, consolidation or otherwise and the term “Common Stock” shall include all such other securities.

      

      

      (d)       Enforcement. Each of the parties hereto agrees that in the event of a breach of any provision of this Agreement, the aggrieved party
          may elect to institute and prosecute proceedings in any court of competent jurisdiction to enforce specific performance or to enjoin the continuing breach of this Agreement. Such remedies, however, shall be cumulative and not exclusive, and shall
          be in addition to any other remedy which any party hereto may have.

      

      

      (e)       Jurisdiction. In any judicial proceeding involving any dispute, controversy or claim arising out of or relating to this Agreement,
          each of the parties hereto unconditionally accepts the non-exclusive jurisdiction and venue of any United States District Court located in the State of Delaware, or of the Court of Chancery of the State of Delaware, and the appellate courts to
          which orders and judgments thereof may be appealed. In any such judicial proceeding, each of the parties hereto agrees that in addition to any method for the service of process permitted or required by such courts, to the fullest extent permitted
          by law, service of process may be made by delivery provided pursuant to the directions in Section 3(h). EACH OF THE PARTIES HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF OR
          RELATING TO THIS AGREEMENT.

      

      

      
        4

        
          

      

      (f)       Successors and Assigns. Except as otherwise provided herein, the provisions of this Agreement shall be binding upon and inure to the
          benefit of the parties hereto and their respective heirs, legal representatives, successors and permitted assigns.

      

      

      (g)       Entire Agreement; Termination. This Agreement constitutes the full and entire understanding and agreement between the parties with
          regard to the subject matter hereof and supersedes all prior oral or written (and all contemporaneous oral) agreements or understandings with respect to the subject matter hereof. This Agreement shall terminate and be of no further force and
          effect at such time as the Altaris Funds cease to beneficially own at least 10% of the total number of shares of Common Stock outstanding.

      

      

      (h)       Notices. All notices, requests, demands, waivers, consents and other communications required or permitted to be given under this
          Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered personally, (b) mailed by certified or registered mail with postage prepaid, (c) sent by next-day or overnight mail or delivery with proof of receipt
          maintained or (d) sent by fax, to the following addresses (or to such other address as the party entitled to notice shall hereafter designate in accordance with the terms hereof):

      

      

      If to the Company:

      

      

      Trean Insurance Group, Inc.

      150 Lakes West Street

      Wayzata, MN 55391

      Attention: Andrew O’Brien

      Facsimile No.: (952) 974-2222

      

      

      If to the Altaris Funds:

      

      

      c/o Altaris Capital Partners, LLC

      10 East 53rd Street, 31st floor

      New York, NY 10022

      Attention: Daniel Tully and David Ellison

      Facsimile No.: (212) 931-0236

       

      

      
        5

        
          

      

      with a copy (which shall not constitute notice) to:

      

      

      Skadden, Arps, Slate, Meagher & Flom LLP

      One Manhattan West

      New York, NY 10001

      Attention: Dwight S. Yoo

      Facsimile No.: (917) 777-2573

      

      

      All such notices, requests, demands, waivers, consents and other communications shall be deemed to have been received by (a) if by personal delivery, on the day delivered, (b) if by electronic delivery, on the day
        delivered, provided that such delivery is confirmed (c) if by certified or registered mail, on the fifth business day after the mailing thereof, (d) if by next-day or overnight mail or delivery, on the day delivered, or (e) if by fax, on the day
        delivered, provided that such delivery is confirmed.

      

      

      (i)        Waiver. Waiver by any party hereto of any breach or default by the other party of any of the terms of this Agreement shall not
          operate as a waiver of any other breach or default, whether similar to or different from the breach or default waived. No waiver of any provision of this Agreement shall be implied from any course of dealing between the parties hereto or from any
          failure by either party to assert its or his or her rights hereunder on any occasion or series of occasions.

      

      

      (j)        Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original but all of
          which together shall constitute one and the same instrument.

      

      

      (k)       Headings. The headings in this Agreement are for the convenience of the parties only and shall not control or affect the meaning or
          construction of any provision hereof.

      

      

      (l)        Invalidity of Provision. The invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall not affect
          the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision, in any other jurisdiction.

      

      

      (m)      Amendments and Waivers. The provisions of this Agreement may be amended at any time and from time to time, and particular provisions
          of this Agreement may be waived or modified, with and only with an agreement or consent in writing signed by each of the parties hereto.

      

      

      (n)       Further Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and things and
          shall execute and deliver all such other agreements, certificates, instruments and documents as any other party hereto or Person subject hereto may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement.
          The Company shall not directly or indirectly take any action that is intended to, or would reasonably be expected to result in, the Altaris Funds being deprived of the rights contemplated by this Agreement.

      

      

      
        6

        
          

      

      (o)       No Third-Party Beneficiaries. This Agreement is not intended to, and does not, confer upon any Person other than the parties hereto
          any rights or remedies.

      

      

      [Remainder of Page Intentionally Left Blank]

      

      

      
        7

        
          

      

      IN WITNESS WHEREOF this Agreement has been signed by each of the parties hereto, and shall be effective as of the date first above written.

      

      

      	 	
              TREAN INSURANCE GROUP, INC.

            
	 	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

            	
              Andrew O’Brien

            
	 	 	
              Title:

            	
              President and Chief Executive Officer

            

      

      

      	 	
              AHP-BHC LLC

            
	 	 	 
	 	
              By:

            	
              Altaris Health Partners III, L.P.,

            
	 	 	
              its Sole Member

            
	 	 	 
	 	
              By:

            	
              AHP III GP, L.P.

            
	 	 	
              its General Partner

            
	 	 	 
	 	
              By:

            	
              Altaris Partners, LLC

            
	 	 	
              its General Partner

            

      

      

      	 	
              By:

            	

            
	 	 	
              Name:

            	
              Daniel Tully

            
	 	 	
              Title:

            	
              Managing Director

            

      

      

      	 	
              AHP-TH LLC

            
	 	 	 
	 	
              By:

            	
              Altaris Health Partners III, L.P.,

            
	 	 	
              its Sole Member

            
	 	 	 
	 	
              By:

            	
              AHP III GP, L.P.

            
	 	 	
              its General Partner

            
	 	 	 
	 	
              By:

            	
              Altaris Partners, LLC

            
	 	

            	
              its General Partner

            

      

      

      	 	By:	
              

              

            
	 	 	
              Name: 

              

            	Daniel Tully
	 	 	
              Title:

            	
              Managing Director

            

      

      

      
        [Signature Page to Director Nomination Agreement]

      

      

      

      
        
          

      

      	 	
              ACP-BHC LLC

            
	 	 	 
	 	
              By:

            	
              Altaris Constellation Partners, L.P.

            
	 	

            	
              its Sole Member

            
	 	 	 
	 	
              By:

            	
              AHP Constellation GP, L.P.

            
	 	

            	
              its General Partner

            
	 	 	 
	 	
              By:

            	
              Altaris Partners, LLC

            
	 	

            	
              its General Partner

            

      

      

      	 	
              By:

            	
              

              

            
	 	 	
              Name: 

              

            	Daniel Tully
	 	 	
              Title:

            	
              Managing Director

            

      

      

      	 	
              ACP-TH LLC

            
	 	 	 
	 	
              By:

            	
              Altaris Constellation Partners, L.P.

            
	 	

            	
              its Sole Member

            
	 	 	 
	 	
              By:

            	
              AHP Constellation GP, L.P.

            
	 	

            	
              its General Partner

            
	 	 	 
	 	
              By:

            	
              Altaris Partners, LLC

            
	 	

            	
              its General Partner

            

      

      

      	 	
              By:

            	

            
	 	 	
              Name: 

              

            	Daniel Tully
	 	 	
              Title:

            	
              Managing Director

            

      

      

      
        [Signature Page to Director Nomination Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]